Gapping up
In reaction to strong earnings/guidance:
- OZK +14.3%, TEAM +8.4%, STI +4.9%, SLB +3%, VFC +2.4%, KSU +1.8%, GME +1.6%, STT +1.5%
Other news:
- GPOR +8.8% (announces 2019 capital budget and new $400 mln stock repurchase program)
- FANH +3.3% (responds to unusual trading in stock, says volatility was caused by a report which made groundless accusations and deliberate out-of-context misinterpretations) CGC +2.9% (ongoing volatility)
- ACB +2.6% (modestly rebounding; prices previously announced offering of convertible senior notes due 2024)
- CVS +2.5% (CVS Health and Walmart (WMT) reach new multi-year agreement for Walmart to continue participating in the CVS Caremark pharmacy benefit management commercial and Managed Medicaid retail pharmacy networks)
- PCG +1.6% (modestly rebounding)
- CVI +1.4% (CVR Energy reports exercise of right to purchase common units of CVR Refining)
- AZN +1.1% (Linzess approved in China for the treatment of irritable bowel syndrome with constipation) .
Analyst comments:
- SPWH +9% (upgraded to Overweight from Neutral at Piper Jaffray)
- SPB +0.9% (upgraded to Buy from Neutral at BofA/Merrill)
- CVX +0.8% (upgraded to Buy from Neutral at UBS )
